These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26002728)

  • 21. Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial.
    Erol Doğan Ö; Karaca Çelik KE; Baş M; Alan EH; Çağın YF
    Nutrients; 2024 May; 16(10):. PubMed ID: 38794742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of selenium supplementation on disease activity and immune-inflammatory biomarkers in patients with mild-to-moderate ulcerative colitis: a randomized, double-blind, placebo-controlled clinical trial.
    Khazdouz M; Daryani NE; Cheraghpour M; Alborzi F; Hasani M; Ghavami SB; Shidfar F
    Eur J Nutr; 2023 Dec; 62(8):3125-3134. PubMed ID: 37525068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis.
    de Bièvre MA; Vrij AA; Schoon EJ; Dijkstra G; de Jong AE; Oberndorff-Klein Woolthuis AH; Hemker HC; Stockbrügger RW
    Inflamm Bowel Dis; 2007 Jun; 13(6):753-8. PubMed ID: 17260365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; Feagan BG; Marano C; Zhang H; Strauss R; Johanns J; Adedokun OJ; Guzzo C; Colombel JF; Reinisch W; Gibson PR; Collins J; Järnerot G; Rutgeerts P;
    Gastroenterology; 2014 Jan; 146(1):96-109.e1. PubMed ID: 23770005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life correlates with clinical and endoscopic activity indexes but not with demographic features in patients with ulcerative colitis.
    Zahn A; Hinz U; Karner M; Ehehalt R; Stremmel W
    Inflamm Bowel Dis; 2006 Nov; 12(11):1058-67. PubMed ID: 17075347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
    Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy.
    Baird AC; Mallon D; Radford-Smith G; Boyer J; Piche T; Prescott SL; Lawrance IC; Tulic MK
    World J Gastroenterol; 2016 Nov; 22(41):9104-9116. PubMed ID: 27895398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a Medicinal Agaricus blazei Murill-Based Mushroom Extract, AndoSan™, on Symptoms, Fatigue and Quality of Life in Patients with Ulcerative Colitis in a Randomized Single-Blinded Placebo Controlled Study.
    Therkelsen SP; Hetland G; Lyberg T; Lygren I; Johnson E
    PLoS One; 2016; 11(3):e0150191. PubMed ID: 26933886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.
    Sadeghi O; Milajerdi A; Siadat SD; Keshavarz SA; Sima AR; Vahedi H; Adibi P; Esmaillzadeh A
    Trials; 2020 Jun; 21(1):565. PubMed ID: 32576228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of resveratrol on markers of oxidative stress in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial.
    Seyyedebrahimi S; Khodabandehloo H; Nasli Esfahani E; Meshkani R
    Acta Diabetol; 2018 Apr; 55(4):341-353. PubMed ID: 29357033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
    Chojnacki C; Wisniewska-Jarosinska M; Walecka-Kapica E; Klupinska G; Jaworek J; Chojnacki J
    J Physiol Pharmacol; 2011 Jun; 62(3):327-34. PubMed ID: 21893693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of saffron supplementation on oxidative/antioxidant status and severity of disease in ulcerative colitis patients: A randomized, double-blind, placebo-controlled study.
    Tahvilian N; Masoodi M; Faghihi Kashani A; Vafa M; Aryaeian N; Heydarian A; Hosseini A; Moradi N; Farsi F
    Phytother Res; 2021 Feb; 35(2):946-953. PubMed ID: 33015869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis.
    Dryden GW; Lam A; Beatty K; Qazzaz HH; McClain CJ
    Inflamm Bowel Dis; 2013 Aug; 19(9):1904-12. PubMed ID: 23846486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polydatin ameliorates DSS-induced colitis in mice through inhibition of nuclear factor-kappaB activation.
    Yao J; Wang JY; Liu L; Zeng WS; Li YX; Xun AY; Zhao L; Jia CH; Feng JL; Wei XX; Wang LS
    Planta Med; 2011 Mar; 77(5):421-7. PubMed ID: 20979017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
    Sandborn WJ; van Assche G; Reinisch W; Colombel JF; D'Haens G; Wolf DC; Kron M; Tighe MB; Lazar A; Thakkar RB
    Gastroenterology; 2012 Feb; 142(2):257-65.e1-3. PubMed ID: 22062358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis.
    D'Haens GR; Kovács A; Vergauwe P; Nagy F; Molnár T; Bouhnik Y; Weiss W; Brunner H; Lavergne-Slove A; Binelli D; Di Stefano AF; Marteau P
    J Crohns Colitis; 2010 Jun; 4(2):153-60. PubMed ID: 21122499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease.
    Tomé-Carneiro J; Gonzálvez M; Larrosa M; Yáñez-Gascón MJ; García-Almagro FJ; Ruiz-Ros JA; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):37-48. PubMed ID: 23224687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol and inflammatory bowel disease.
    Shi Y; Zhou J; Jiang B; Miao M
    Ann N Y Acad Sci; 2017 Sep; 1403(1):38-47. PubMed ID: 28945937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
    Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.